Heow Tan

Heow joined Biomea Fusion, Inc. in November 2020. At Biomea, Heow is the Chief Technical & Quality Officer and is responsible for all aspects of CMC development, manufacturing, supply chain and Quality Operations. Heow brings 35 years of pharmaceutical industry experience in these areas. Prior to Biomea, Heow was the CTO for Pharmacyclics with similar responsibilities and was instrumental in scaling-up and getting the CMC section of Imbruvica NDA, with its 4 Breakthrough Therapy Designations approved. He helped grow Imbruvica to more than USD 5 billion worldwide revenue. Prior to Pharmacyclics, he was at Collegium Pharmaceutical where he served as Senior Vice President, Technical Operations. Before that, he was the Vice President, Industrial Operations and Development at Praecis Pharmaceuticals. Throughout his career, he has served in similar roles at many biopharmaceutical companies throughout the San Francisco Bay Area. Heow received his BS in Industrial and Systems Engineering and an MS in Engineering from The Ohio State University. He also holds an MBA from Santa Clara University.